FDA Grants Emergency Use Authorizations for Access Bio, Truvian Sciences Coronavirus Antibody Tests

The US Food and Drug Administration has granted separate Emergency Use Authorizations (EUAs) for SARS-CoV-2 antibody tests developed by Access Bio and Truvian Sciences.